Scleroderma
Diffuse cutaneous systemic sclerosis is characterised by:
| A |
Early pulmonary fibrosis |
|
| B |
Raynauds phenomenon |
|
| C |
Calcinosis cutis |
|
| D |
Long term prognosis is better |
Diffuse cutaneous systemic sclerosis is characterised by:
| A |
Early pulmonary fibrosis |
|
| B |
Raynauds phenomenon |
|
| C |
Calcinosis cutis |
|
| D |
Long term prognosis is better |
Diffuse cutaneous SSc is associated with
In late stages of systemic sclerosis may have all the given features, EXCEPT:
| A |
Pulmonary artery hypertension |
|
| B |
Interstitial lung diserase |
|
| C |
Primary biliary cirrhosis |
|
| D |
Primary sclerosing cholangitis |
In late stages of systemic sclerosis may have all the given features, EXCEPT:
| A |
Pulmonary artery hypertension |
|
| B |
Interstitial lung diserase |
|
| C |
Primary biliary cirrhosis |
|
| D |
Primary sclerosing cholangitis |
Late stages of limited systemic sclerosis patients may develop
- Pulmonary arterial hypertension (PAH),
- Interstitial lung disease,
- Hypothyroidism,
- Primary biliary cirrhosis
Limited cutaneous systemic sclerosis have the following characteristic autoantibody positivity:
| A |
Anti Topoisomerase I |
|
| B |
Anti-RNA polymerase III |
|
| C |
Scl-70 |
|
| D |
Anticentromere |
Limited cutaneous systemic sclerosis have the following characteristic autoantibody positivity:
| A |
Anti Topoisomerase I |
|
| B |
Anti-RNA polymerase III |
|
| C |
Scl-70 |
|
| D |
Anticentromere |
Subset of systemic sclerosis limited cutaneous scleroderma has the following features:
- Skin involvement-Indolent onset and progression. Limited to fingers.
- Raynaud’s phenomenon-Precedes skin involvement; associated with critical ischemia
- Pulmonary artery hypertension-Frequent, late, may be isolated
- Pulmonary fibrosis – rare
- scleroderma renal crisis-Very rare
- Calcinosis cutis-Frequent, prominent
- Characteristic autoantibodies-Anti Centromere
All of the following statements regarding systemic sclerosis are TRUE, EXCEPT:
| A |
Increased serum antibodies to human cytomegalovirus are seen |
|
| B |
Eosinophilia myalgia syndrome is a subtype of systemic sclerosis |
|
| C |
The incidence of SSc is increased among miners exposed to silica |
|
| D |
Bleomycin, pentazocine and cocaine may produce systemic sclerosis like illness |
All of the following statements regarding systemic sclerosis are TRUE, EXCEPT:
| A |
Increased serum antibodies to human cytomegalovirus are seen |
|
| B |
Eosinophilia myalgia syndrome is a subtype of systemic sclerosis |
|
| C |
The incidence of SSc is increased among miners exposed to silica |
|
| D |
Bleomycin, pentazocine and cocaine may produce systemic sclerosis like illness |
Patients with systemic sclerosis:
- Have increased serum antibodies to human cytomegalovirus (hCMV)
- Evidence of human parvovirus B19 infection is seen
- It is more in miners exposed to silica.
- It is more in polyvinyl chloride, epoxy resins, and aromatic hydrocarbons including toluene and trichloroethylene exposures.
- Bleomycin, pentazocine and cocaine are implicated with systemic sclerosis
- Women with silicone breast implants-more risk
Features of systemic sclerosis are –
| A |
Calcinosis |
|
| B |
Sclerodactyly |
|
| C |
Raynaud’s phenomena |
|
| D |
All |
Features of systemic sclerosis are –
| A |
Calcinosis |
|
| B |
Sclerodactyly |
|
| C |
Raynaud’s phenomena |
|
| D |
All |
Ans. is ‘a’ i.e., Calcinosis; ‘b’ i.e., Sclerodactyly & ‘c’ i.e., Raynaud’s phenomena
Systemic sclerosis (scleroderma)
- Systemic sclerosis is a chronic disease of unknown etiology characterized by abnormal accumulation of fibrous tissue in skin and multiple organs.
- Systemic sclerosis is primarily a disease of female.
o The most common age is 30-50 years.
(Note – Robbin’s has given 50-60 years. I went through many other books and various articles. According to them the age group is 30-50 years).
o It is characterized by excessive fibrosis throughout the body.
o The skin is most commonly affected, but the GIT, kidney, heart, muscles and lungs also are involved. Classification
- Systemic sclerosis (scleroderma) has been classified into two major categories –
1.Diffuse scleroderma
o Wide spread skin involvement at onset.
- Rapid progression and early skin involvement.
2. Limited scleroderma
- Skin involvement is confined to fingers, forearm and face.
o Visceral involvement is late.
- Progression is slow and relatively benign.
- Some patients with limited disease also develop a combination of calcinosis, sclerodactyly, Raynaud phenomenon, Esophageal dysmotility, Sclerodactyly and telengectasis, called the CREST syndrome. Note ‑
o Calcinosis –> Subcutaneous calcification of finger and along extensor surface of forearm.
o Raynaud phenomenon —> Episodic vasoconstriction of arteries and arterioles of the extremities.
o Sclerodactyly –> Skin fibrosis and thickening limited to fingers and toes.
o Telengectasis —> Dilated capillaries.
All of the following features about generalized (diffuse) systemic sclerosis are true, Except:
| A |
Raynaud’s phenomenon seen years before skin changes |
|
| B |
Trunk involvement |
|
| C |
Anti centromere antibodies are characteristic |
|
| D |
Frequent systemic symptoms |
All of the following features about generalized (diffuse) systemic sclerosis are true, Except:
| A |
Raynaud’s phenomenon seen years before skin changes |
|
| B |
Trunk involvement |
|
| C |
Anti centromere antibodies are characteristic |
|
| D |
Frequent systemic symptoms |
Answer is C (Anticentromere antibodies are characteristic):
Antitopoisomerase antibodies (Scl 70) are characteristic of diffuse systemic sclerosis and not Anticentromere antibodies.
Subsets of systemic sclerosis (SSC): Limited cutaneous SSC versus diffuse cutaneous:
|
Features |
Limited cutaneous SSc |
Diffuse cutaneous SSc |
|
Skin involvement |
Limited to fingers, distal to elbows, face; slow progression |
Diffuse: finger, extremities, face, trunk; rapid progression |
|
Raynaud’s phenomenon |
Preceds skin involvement; associated with critical ischemia |
Onset contemporaneous with skin involvement |
|
Pulmonary fibrosis |
May occur, moderate |
Frequent, early and severe |
|
Pulmonary arterial hypertension |
Frequent, late, may be isolated |
May occur, associated with pulmonary fibrosis |
|
Scleroderma renal crisis |
Very rare |
Occurs in 15%; early |
|
Calcinosis cutis |
Frequent, prominent |
May occur, mild |
|
Characteristic autoantibodies |
Anticentromere |
Antitopoisomerase (Scl – 70) |
|
Systemic symptoms |
Infrequent systemic symptoms such as Arthralgias, weight loss and pulmonary symptoms |
Significant systemic symptoms such as Arthralgias, weight loss and tendon friction rubs |
Features of systemic sclerosis include all of the following, Except:
| A |
Calcinosis |
|
| B |
Sclerodactyly |
|
| C |
Hyperpigmentation (Melanin deposition) |
|
| D |
More common in young patients |
Features of systemic sclerosis include all of the following, Except:
| A |
Calcinosis |
|
| B |
Sclerodactyly |
|
| C |
Hyperpigmentation (Melanin deposition) |
|
| D |
More common in young patients |
Answer is D (More common in young patients):
Systemic sclerosis is primarily a disease of adults and the mean age of presentation is around 50 years.
Systemic sclerosis is not a disease of young individuals
The mean age of presentation of systemic sclerosis is 50 years — Current Diagnosis & Treatment in Rheumatology 2nd/228 The peak incidence of systemic sclerosis is 50-60 years — Robbins 7th/239
The most common age of onset in the range of 30-50 years — Harrison 171h/2097
Systemic sclerosis is more common in women
Like other connective tissue disorders systemic sclerosis shows a female predominance- Harrison 17th/2097 Systemic sclerosis is primarily a disease of women (female to male ratio is 3: I) — Robbin,s
Systemic sclerosis may present with Calcinosis, Sclerodactyly and hyperpiamentation
The skin of extremities and trunk may be darkly pigmented. Diffuse tanning in the absence of sun exposure may be a very early manifestation of skin involvement — Harrisons
Calcinosis and sclerodactyly are part of the ‘Crest syndrome’ in limited systemic sclerosis
|
CREST syndrome |
|
|
C |
Calcinosis |
|
R |
Raynauld’s |
|
E |
Esophageal dysmotility |
|
S |
Sclerodactyly |
|
T |
Telengactasia |




